Drug Profile
Research programme: therapeutic oxygen-carrying proteins - New Beta Innovation
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator New Beta Innovation
- Class Proteins
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Unspecified in Hong Kong
- 09 Aug 2016 Early research in Undefined indication in Hong Kong (unspecified route)